Background
==========

A large resource of deletion strains (also known as genetic deficiencies) accounting for over 70% of the *Caenorhabditis elegans*genome has been generated by various research groups over the past three decades \[[@B1]\]. These genetic deficiencies have proven advantageous for a variety of purposes including; characterization of mutant alleles \[[@B2]\], identification of specific loci affecting developmental processes \[[@B3]\], investigation of genome replication and stability \[[@B4],[@B5]\] and, most significantly, as tools for positional cloning of unmapped mutations to discrete regions of the genome \[[@B1],[@B6]-[@B8]\].

The full potential of these biological tools has however been limited due to the lack of high resolution characterization at a genome wide scale. The mapping of physical breakpoint positions within each deficiency strain is required to allow the deleted gene complement for that strain to be precisely defined. Additionally, genetic deficiencies may exhibit molecular complexity preventing their reliable use in mapping experiments \[[@B9]\].

Previously, characterization of genetic deficiencies has been performed by fairly low resolution or labor intensive techniques such as genetic linkage mapping, PCR analysis \[[@B7]\] and, more recently, by the application of snip-SNP \[[@B9],[@B10]\] and as a consequence many available deficiency strains remain poorly characterized.

Oligonucleotide array Comparative Genomic Analysis (oaCGH) is an emerging technology for high resolution mapping of chromosomal copy number changes at a genome wide scale through the comparison of the DNA ratio between two samples from the same organism \[[@B11],[@B12]\]. The recent development of a *C. elegans*specific oaCGH platform for identification of novel single gene deletions \[[@B13]\] represents a powerful technology that can be adapted to the rapid and precise characterization of deficiency mapping strains.

In this study we demonstrate the successful application of oaCGH to the physical characterization of deficiency strains in *C. elegans*. We use this data to annotate a physical deficiency map within a 5 Mb region of chromosome III and demonstrate the application of this map to aid in the molecular identification of previously generated mutations known to reside within this region.

Results and Discussion
======================

oaCGH mapped deletions and duplications physically define 17 zones around the dpy-17 region of Chromosome III
-------------------------------------------------------------------------------------------------------------

7 deficiencies and 2 duplications lying in the region of *dpy-17*on chromosome III were chosen for oaCGH analysis (Nimblegen) as they have been previously characterized by both genetic linkage and PCR analysis, and used to roughly position a large number of unidentified EMS generated lethal mutants \[[@B7]\]. After oaCGH mapping had precisely defined the gene complement for each of these deficiencies a refined candidate gene approach was implemented to rapidly identify mutations in essential genes which map to this region.

Available mapping data for deficiency strains positioned deletion and duplication breakpoints with an average resolution of 117 kb. With the incorporation of the oaCGH data however, breakpoints resolved to within an average of 5.6 kb and subsequent analysis through PCR amplification and sequencing allowed for the identification of precise physical breakpoints in strains containing *nDf20, sDf121*, *sDf125*, *sD128*and *sDf135*(Table [1](#T1){ref-type="table"}). The remaining deficiency strains, *sDf127*and *sDf130*, both contain breakpoints which reside in relatively large intergenic regions and since the oaCGH array used for these samples has low probe density in intergenic regions \[[@B13]\] PCR and sequencing analysis was not feasible in these cases.

###### 

Summary of mapping resolution for deficiencies using both genetic and molecular mapping techniques.

                                                   Genetic/PCR Mapping Data   oaCGH Mapping Data   ^*a*^Sequenced Breakpoint Coordinates                                 
  ------------------------- ---------- ----- ----- -------------------------- -------------------- --------------------------------------- --------- --------- --------- -----------------
  MT3022                    *nDf20*    GRI   Out   *egl-5*                    *sma-2*              7895240                                 8678216   7896734   8676211   780
                                             In    *lin-36*                   *dpy-19*             7900966                                 8676164                       
  BC4698                    *sDf121*   GRI   Out   F10G11                     C05D2                4568979                                 5637318   4568042   5637312   1069
                                             In    F35G12                     F54E7                4569058                                 5636068                       
  BC4634                    *sDf125*   UVI   Out   F42A10                     K04C2                6178564                                 6620842   6178994   6620106   441
                                             In    C23G10                     R13F6                6181034                                 6619737                       
  BC4638                    *sDf127*   UVI   Out   C23G10                     R13A5                6200904                                 7453868   ND        ND        ^*d*^1194--1253
                                             In    C23G10                     T20B12               6200951                                 7395215                       
  BC4690                    *sDf128*   GRI   Out   C29E4                      C06G4                7945153                                 8023540   7945392   8023387   78
                                             In    C06G4                      F44B9                7945526                                 8019512                       
  BC4637                    *sDf130*   UV    Out   C32A3                      C05D2                3640014                                 5566628   3640101   5565581   1925
                                             In                                                    3640119                                 5565449                       
                                             Out                                                   5635618                                 5664335   ND        ND        ^*e*^16--29
                                             In    R13G10                     ZC155                5645065                                 5661035                       
  BC4677                    *sDf135*   GRI   Out   B0361                      T20B12               7276848                                 7479897   7277386   7476402   199
                                             In    T20B12                     R13A5                7277471                                 7467958                       
  ^*b*^NA                   *sDp3*     GRI   Out   *daf-7*                    *dpy-19*             ^*c*^Complex                            8611252   NA        NA        NA
                                             In    *dpy-18*                   *mig-10*                                                     8611166                       
  BC3737                    *sDp8*     UVI   Out   *let-721*                  *sma-2*              6559307                                 8714234   NA        NA        NA
                                             In    M01G4                      *dpy-19*             6562088                                 8710120                       
                                                                                                                                                                         
  Average resolution (kb)   117        5.6   0     0                                                                                                                     

^*a*^Breakpoint coordinates aligned to Wormbase (release WS170).

^*b*^*sDp3*structure is inferred from the background of the oaCGH data.

^*c*^The left breakpoint of *sDp3*is fragmented over a large region.

^*d*^The right breakpoint of *sDf127*falls within a 50 kb region of low complexity and therefore low probe density and could not be accurately defined.

^*e*^The second deleted region in *sDf130*was not be resolved by PCR analysis.

By using the refined mapping data obtained from the oaCGH analysis we annotated the deleted gene complement within each mapping strain, creating a physical map of zones defined by the overlap of the deficiencies and duplications within the region. The resulting map extends across almost 5 Mb of the genome and contains 17 zones with an average size of 323 kb (Figure [1](#F1){ref-type="fig"}). Zone 13 is the largest region, covering 929 kb and containing 204 predicted genes, while zone 8 is the smallest at 22 kb and contains 5 predicted genes (Table [2](#T2){ref-type="table"}). Finally, positional mapping data available for mutations known to fall within this region was incorporated into the map, and in this way we have been able to assign each mutation to an accurate and precisely defined list of gene candidates (Figure [1](#F1){ref-type="fig"}. and Additional file [1](#S1){ref-type="supplementary-material"}).

![**A revised genetic and physical map of the *dpy-17*region of chromosome III after incorporation of oaCGH deficiency mapping data**. Deficiencies are represented as single lines and duplications as double lines. The outermost genes residing within each deficiency are shown. 17 zones defined by the deficiencies and duplications are represented by grey boxes. Note that the transition between zones 11 and 12 is defined by the position of *dpy-17*. \*8 lethal mutants have not been positioned left/right with respect to *dpy-17*. Figure is not to scale.](1471-2164-8-402-1){#F1}

###### 

Physical and genetic structure of zones 1A-14.

  Zone      Start (bp)   End (bp)   Left Gene   Right Gene   Size (kb)   \# genes   ^*b*^\# RNAi Lethal   \# Lethal Mutants
  --------- ------------ ---------- ----------- ------------ ----------- ---------- --------------------- -------------------
  1A        8023387      8611252    F44B9.2     *rha-2*      588         151        39                    12
  1B        7945392      8023387    *kle-2*     F44B9.2      78          23         6                     3
  2A        7896734      7945392    ZK688.2     *kle-2*      49          14         5                     0
  2B        7476402      7896734    H14A12.5    ZK688.2      420         81         23                    11
  3         7395219      7476402    T20B12.9    H14A12.5     81          8          5                     1
  4         7277442      7395219    B0361.11    T20B12.9     118         35         11                    1
  5         6620106      7277442    Y40D12A.1   B0361.11     657         154        48                    13
  6         6559307      6620106    F27B3.5     Y40D12A.1    61          14         4                     2
  7         6200904      6562088    *rpn-2*     F27B3.5      361         97         25                    15
  8         6178994      6200951    *nas-28*    *rpn-2*      22          5          3                     0
  9         5662800      6178564    *par-3*     *nas-28*     516         123        29                    7
  ^*a*^13   5637312      5664335    *ckk-1*     *par-3*      27          5          1                     0
  10        5565581      5637312    *mlc-3*     *ckk-1*      72          18         2                     0
  11        5107800      5565581    *dpy-17*    *mlc-3*      458         98         31                    7 ^*c*^(+/- 8)
  12        4569043      5107800    F35G12.2    *dpy-17*     539         163        46                    14 ^*c*^(+/- 8)
  13        3640101      4569043    C32A3.3     F35G21.1     929         204        54                    13
  14        3115819      3640101    Y53G8B.1    C32A3.3      524         85         21                    9

^*a*^Zones 11 and 12 are defined by *dpy-17*.

^*b*^RNAi Lethal encompasses all genes annotated in Wormbase (release WS170) as having either emb, let, lvl and/or ste phenotypes by RNAi.

^*c*^8 lethal mutations have not been position right/left with respect to *dpy-17*.

The free translocation sDp3 undergoes significant modification within deficiency strains
----------------------------------------------------------------------------------------

In our initial set of experiments we performed oaCGH using genomic DNA from three representative deficiency strains balanced by the free duplication *sDp3*; BC4697 (*sDf121(s2098) \[sDp3\])*, BC4638 (*sDf127(s2428) \[sDp3\])*and BC4690 (*sDf128(s2786) \[sDp3\])*(Figure [2](#F2){ref-type="fig"}), using wild type Bristol N2 DNA as the reference sample. The expected ratio of reference DNA to test using this approach is 1:1 over the region of the chromosome not covered by *sDp3*, 2:3 over the region covered by *sDp3*alone and 2:1 in the region of the deficiency balanced by *sDp3*(Figure [2A](#F2){ref-type="fig"}).

![**oaCGH experimental overview and *sDp3*balanced deficiency data**. (A-B) Schematic representation of the oaCGH experimental approaches; (A) using *sDp3*balanced deficiency strains and (B) modified to use *hT2 (qIs48)*heterozygous balancer. Colored bars beneath schematic indicate expected DNA ratios. (C-E) oaCGH data obtained in GFF file format for three *sDp3*balanced deficiency strains visualized using the SignalMap™ browser software \[20\]. (C) BC4697 (*sDf121 \[sDp3\])*, (D) BC4638 (*sDf127 \[sDp3\])*and (E) BC4690 (*sDf128 \[sDp3\])*. Regions covered by *sDp3*are represented as blue lines above the data; deletions are represented by red lines below the data. (F) Expansion of oaCGH data across the left breakpoint region of *sDf121*. Region of deletion ambiguity is represented by broken lines. \*Apparent internal duplications of *sDp3*.](1471-2164-8-402-2){#F2}

This initial analysis revealed that the extent of *sDp3*varies dramatically between each of the strains tested (Figure [2B--D](#F2){ref-type="fig"}). Since duplications maintained in balancer strains are known to breakdown both spontaneously and under the mutagenic conditions used to induce deficiencies \[[@B14]-[@B16]\] it is likely that the observed modifications to *sDp3*are as a result of these factors.

In addition to the variability of *sDp3*coverage, discrete duplications internal to *sDp3*are observed within each of the strains tested (Figure [2](#F2){ref-type="fig"}). This lack of uniformity makes determination of deficiency structure problematic in some cases. For example, the presence of an internal duplication in BC4697 across the region containing the left breakpoint of *sDf121*results in an increase of predicted copy number in this region (Figure [2F](#F2){ref-type="fig"}), while multiple variations within both *sDp3*balanced strains containing *sDf127*and *sDf128*complicates the distinction between where DNA has been deleted or duplicated (Figure [2C--E](#F2){ref-type="fig"} and data not shown).

oaCGH of heterozygous deficiencies resolves copy number ambiguity and results in precise mapping of deletion breakpoints
------------------------------------------------------------------------------------------------------------------------

Since heterozygous deletions can be easily resolved with oaCGH \[[@B13]\] we surmised that the creation of single copy deficiency strains would eliminate the ambiguity introduced through the use of the *sDp3*balancer. By using this approach the expected ratio of reference DNA to test is 1:1 along the whole length of the chromosome except within the deleted region where a ratio of 2:1 will be expected (Figure [2B](#F2){ref-type="fig"}).

To implement this strategy all of the *sDp3*balanced deficiency strains to be tested were out-crossed to JK2689, which contains the GFP marked heterozygous balancer *hT2 (qIs48)*known to cover the region under investigation in this study \[[@B1]\]. For this analysis genomic JK2689 DNA was used as the reference sample to eliminate any genomic variability that may have been introduced into this strain through the heavy mutagenesis used for its original construction \[[@B17]\].

With the elimination of *sDp3*from the background the ability to accurately resolve breakpoint positions in the ambiguously mapped deficiency strains improved significantly. A comparison of oaCGH data for *sDf127*balanced by *sDp3*and this same deficiency out-crossed to *hT2 (qIs48)*highlights this improvement (Figure [3](#F3){ref-type="fig"}). As part of their construction, deficiency strains have been out-crossed several times and it is therefore unlikely that the process of creating the *hT2*balanced strains has removed any features of these deficiencies. The oaCGH data obtained for each strain using the modified strategy is therefore likely to represent the initial structure of each of the deficiencies tested.

![**Comparison of oaCGH data in the *sDp3*and *hT2 (qIs48)*balancer backgrounds:**(A) BC4638 *(sDf127 \[sDp3\])*(B) BC7163 *(sDf127/hT2 \[qIs48\])*(C) BC7162 *(sDf125/hT2 \[qIs48\])*. Unambiguous deficiency mapping for each experiment is depicted as a solid black line while ambiguous regions are represented as a dashed grey line. Genes residing at the confirmed *sDf127*breakpoints are shown (grey bars). Non-deficiency specific copy number changes introduced by the background strain can be seen (B and C solid arrows). Note: oaCGH array used in A is the Nimblegen design \[20\] while the array used in B and C is from the exon-centric array described by Mayden et.al \[13\] (see Methods).](1471-2164-8-402-3){#F3}

Combining data from multiple array experiments allows for bias removal resulting in reliable deficiency characterization
------------------------------------------------------------------------------------------------------------------------

oaCGH data obtained from separate strains using the same chip design performs consistently enough to allow for the integration and direct comparison of the data generated from multiple experiments. Through this data integration, common inconsistencies that are not specific to the deletion of interest are identified and eliminated from the annotation, resulting in a reliable characterization of the whole deficiency genome (Figure [3B](#F3){ref-type="fig"} and [3C](#F3){ref-type="fig"}). This is an important step given that small mutagenic events which may have occurred outside the known boundaries of a given deficiency may remain unidentified by traditional mapping methods and could lead to conflicting mapping data.

oaCGH analysis reveals deficiency complexity on a genome-wide scale
-------------------------------------------------------------------

We have analysed a number of deficiencies generated with both GRI and UV irradiation (Table [1](#T1){ref-type="table"} and data not shown), and have been unable to detect any significant mutagen specific deletion characteristics, the majority having a simple contiguous structure (Figure [3B](#F3){ref-type="fig"} and [3C](#F3){ref-type="fig"}, and data not shown). Exceptions to this observation are seen in the deficiencies *sDf130*, which contains two distinct deletions, the smaller of which defines zone 10 (Figure [1](#F1){ref-type="fig"}), and *sDf128*which exhibits associated complexity.

In a similar case as to that seen with *sDp3*balanced *sDf121*, several duplications of various sizes extend into the deficiency region of *sDf128*(Figure [2C](#F2){ref-type="fig"} and [2E](#F2){ref-type="fig"}). Unlike *sDf121*however, these duplications are retained when *sDf128*is out-crossed to *hT2*(Figure [4](#F4){ref-type="fig"}), suggesting that they have been integrated into the deficiency genome. Attempts to further characterize the complexity of *sDf128*through PCR amplification across the predicted deletion breakpoints failed, suggesting that integration of a duplicated region has occurred within the deficiency itself. Subsequent amplification of a PCR product spanning the left end of the largest duplication and the right end of the deleted region confirms the integration of the duplicated fragment within the deletion (Figure [4](#F4){ref-type="fig"}). Confirmation of the structure of the left end of the insertion, or elucidation of the position of the smaller duplicated region, could not be achieved leading to the conclusion that this region is physically complex.

![***sDf128*associated complexity**. (A) BC7164 *(sDf128/hT2 \[qIs48\])*oaCGH data showing retention of duplications. (B) Schematic representation of *sDf128*PCR analysis and confirmed duplication insertion. (C) Predicted insertion of the duplicated region into the *sDf127*genome. (?) Unconfirmed deficiency structure.](1471-2164-8-402-4){#F4}

Accurate identification of lethal mutations positioned within the deficiency map
--------------------------------------------------------------------------------

A more detailed analysis of Zone 1B highlights the value of applying the physical deficiency map to the identification of uncloned mutations. This zone is defined by the deletion breakpoints of the deficiency *sDf128*and contains three molecularly unknown lethal mutants; *let-722*, *let-754*and *let-766*. The region is 78 kb in size, contains 21 predicted genes and is spanned by the cosmids; C29E4, F54H12, C06G4 and F44B9 (Figure [5](#F5){ref-type="fig"}).

![**Schematic representation of zone 1 B as defined by the deficiency *sDf128***. Cosmids as represented as grey bars above predicted gene positions taken from Wormbase (release WS170). Essential Gene candidates as defined by RNAi phenotype are numbered. Identified mutation positions are shown in gene expansions.](1471-2164-8-402-5){#F5}

Since 39 of the 40 molecularly identified lethal mutants in Wormbase \[[@B18]\] exhibit a variety of lethal or sterile RNAi phenotypes (Additional file [1](#S1){ref-type="supplementary-material"}), genes within each zone which display these RNAi phenotypes make good candidates for the lethal mutations mapping to the same region. Of the 21 genes within zone 1 B, only 6 exhibit lethal phenotypes by RNAi (Figure [5](#F5){ref-type="fig"} and Additional file [1](#S1){ref-type="supplementary-material"}) and these 6 genes were consequently taken as initial candidates of the three lethal mutants in this region.

To identify DNA lesions the coding region of each candidate gene was PCR amplified and sequenced using homozygous mutant DNA from a representative lethal strain as template. In this way both *let-722*and *let-754*, were identified as being alleles of *aco-2*and C29E4.8 respectively (summarized in Table [3](#T3){ref-type="table"}). *let-766*however was not identified from this approach and we conclude that this mutation either maps into one of the remaining 19 genes within this region, or a gene outside the deficiency which may have be disrupted through integration of the small unmapped duplication present in this strain.

###### 

Summary of the mutations identified in essential genes as a result of this study.

  Gene      Description                            Genomic Position (bp)   Chromosome   Mutant      Allele    Mutation   Protein Change           RNAi Phenotype   Mutagen
  --------- -------------------------------------- ----------------------- ------------ ----------- --------- ---------- ------------------------ ---------------- ---------
  C16A3.3   RRP5 Ribosomal RNA Processing Enzyme   6383494..6389343        III          *let-716*   *s2457*   G-A        3rd Intron Splice Site   emb              EMS
                                                                                                    *s2626*   TGG-TGA    W1489 *(opal)*                            
  *fum-1*   Fumarase                               7465428..7467668        III          *let-768*   *s2482*   TCG-TTG    S149L                    emb              EMS
                                                                                                    *s2592*   CGT-CAT    R151H                                     
                                                                                                    *s2628*   GGA-AGA    G88R                                      
  C29E4.8   Adenylate Kinase                       7951844..7949909        III          *let-754*   *s2622*   AAG-AAA    R150C                    emb              EMS
  *aco-2*   Aconitase                              7973646..7977254        III          *let-722*   *s2448*   GAA-AAA    E285K                    emb              EMS
                                                                                                    *s2450*   GGG-GGA    G663D                                     
                                                                                                    *s2588*   CGC-CGT    A687V                                     

emb = embryonic lethality

EMS = Ethylmethane Sulphonate

Finally, through the incorporation of mapping data generated by our group from ongoing efforts to clone lethal mutations, we have been able to further identify the mutations *let-716*and *let-768*as alleles of the genes C16A3.3 and *fum-1*, respectively (our unpublished data and summarized in Table [3](#T3){ref-type="table"}).

Conclusion
==========

We have demonstrated that oaCGH can be successfully applied to the rapid and precise characterization of existing *C. elegans*genetic deficiencies. This study highlights how this type of analysis can transform low resolution genetic mapping tools into a precise physical mapping resource with which to accurately position molecularly unidentified mutations.

The implementation of oaCGH technology for this purpose is straightforward, requiring only the preparation of high quality genomic DNA from the deficiency strains of interest. Data is generated in a short time and can be verified experimentally by standard molecular techniques. Some caveats to the application of this methodology have been highlighted by the initial difficulties we describe resulting from the use of animals balanced by a free duplication, though we have demonstrated that by considered evaluation of the experimental approach these issues can be circumvented easily.

We envisage that this resource will be instrumental in resolving previously ambiguous genetic mapping data. Additionally, we propose that integration of a physical deficiency map into a high-throughput molecular mapping strategy such as snip-SNP will improve the efficiency of positional cloning in *C. elegans*. In such an approach snip-SNP would be employed to map the mutant of interest into a sub-chromosomal region, this region could then be further broken up by physically defined deficiencies, and a candidate sequencing pipeline, such as the one we describe here, employed to identify the molecular position of the mutation of interest.

Methods
=======

Nematode culture, harvest, and DNA preparation
----------------------------------------------

Nematodes were grown as previously described \[[@B19]\] on 150 mm NGM agar plates seeded with Escherichia coli strain OP50. Strains used: Bristol N2, JK2689 -- *pop-1(q645) dpy-5(e61) I/hT2 \[bli-4(e937) let-?(q782) qIs48\] (I;III)*, BC4697 -- *sDf121(s2098) unc-32(e189) III; sDp3 (III;f)*, BC7162 -- *dpy-17(e164) sDf125(s2424) unc-32(e189) III; hT2 \[bli-4(e937) let-?(q782) qIs48\]*, BC4638 -- *dpy-17(e164) sDf127(s2428) unc-32(e189) III; sDp3 (III;f)*, BC7163 -- *dpy-17(e164) sDf127(s2428) unc-32(e189) III; hT2 \[bli-4(e937) let-?(q782) qIs48\]*, BC4690 -- *dpy-17(e164) sDf128(s2786) unc-32(e189) III; sDp3 (III;f)*, BC7164 -- *dpy-17(e164) sDf128(s2786) unc-32(e189) III; hT2 \[bli-4(e937) let-?(q782) qIs48\]*, BC7244 -- *sDf130(s2427) unc-32(e189) III; hT2 \[bli-4(e937) let-?(q782) qIs48\]*, BC7181 -- *dpy-17(e164) sDf135(s2767) unc-32(e189) III; hT2 \[bli-4(e937) let-?(q782) qIs48\]*, BC3737 -- *sDp8(III;I); eT1(III;V)*, BC4158 *sDp3(III;f); dpy-17(e164) let-722(s2448) unc-32(e189) III*, BC4160 -- *sDp3(III;f); dpy-17(e164) let-722(s2450) unc-32(e189) III*, BC4228 -- *sDp3(III;f); dpy-17(e164) let-722(s2588) unc-32(e189)*, BC4262 -- *sDp3(III;f); dpy-17(e164) let-754(s2622) unc-32(e189) III*, BC4173 -- *dpy-17(e164) let-766(s2463) unc-32(e189) III; sDp3(III;f)*, BC4167 -- *sDp3(III;f); dpy-17(e164) let-716(s2457) unc-32(e189) III*, BC4266 -- *sDp3(III;f); dpy-17(e164) let-716(s2626) unc-32(e189) III*, BC4192 -- *sDp3(III;f); dpy-17(e164) let-768(s2482) unc-32(e189) III*, BC4232 -- *sDp3(III;f); dpy-17(e164) let-768(s2592) unc-32(e189) III*, BC4268 -- *sDp3(III;f); dpy-17(e164) let-768(s2628) unc-32(e189) III*, BC2842 -- *dpy-18(e364)/eT1 III; unc-46(e177) let-444(s1418)/eT1 \[let-500(s2165)\]V*, MT3022 -- *nDf20/sma-2(e502) unc-32(e189)III*.

DNA preparation for oaCGH samples was done as previously described \[[@B13]\]. For mutant sequencing \~50 homozygous lethal animals were picked from the progeny of *sDp3*balanced strains into 5 ul of lysis buffer (50 mM KCl, 10 mM Tris pH 8.3, 2.5 mM MgCl2, 0.45% Tween-20, 0.01% Gelatin) and freeze cracked in Liquid N2 followed by digestion (1 hour at 60°C followed by 15 min at 95°C). 1 ul of this DNA preparation was subsequently used in a 25 ul PCR reaction.

oaCGH Data analysis
-------------------

For the analysis of *sDp3*balanced strains a *C. elegans*whole genome array was used, based on Wormbase release WS120, and available from NimbleGen Systems Inc. \[[@B20]\]. Analysis of the *hT2 (qIs48)*balanced strains was performed with a whole genome *C. elegans*array designed with overlapping 50-mer probes targeting primarily annotated exons and micro-RNAs \[[@B13]\]. oaCGH sample preparation, hybridization and analysis was done as previously described \[[@B13]\]. Copy number aberrations were detected by visual inspection using the SignalMap™ browser software \[[@B20]\]. The data discussed in this publication have been deposited in NCBIs Gene Expression Omnibus (GEO) \[[@B21]\] and are accessible through GEO Series accession numbers GSE9214 and GPL6047.

Molecular identification of deficiency breakpoints and mutations
----------------------------------------------------------------

PCR amplification across the region of the breakpoint was performed with nested primers (Primer sequences and amplification conditions available upon request) and sequenced using standard molecular methods.
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